Rick Doblin, Ph.D.

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary's Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife, dog, and empty rooms from three children, one of whom is in college and two have graduated.

“The Collective Insights podcast is great for people who realize we have to take our health into our own hands. The guest interviews are world leading experts on their topics. As they say about apples, one Collective Insights podcasts a day, keeps the doctor away.” -Rick Doblin, Ph.D


Learn More:

  1. MAPS
  2. Zendo Project
  3. Book: Manifesting Minds: A Review of Psychedelics in Science, Medicine, Sex, and Spirituality
  4. TED Talk: The future of psychedelic-assisted psychotherapy
  5. Podcast: Rick Doblin on The Joe Rogan Experience
  6. Podcast: Rick Doblin on The Peter Attia Drive

More from Neurohacker:

  1. Podcast: Psychedelic Research From MAPS: The Impact of Psychedelics on Our World
  2. Blog: Transcript: Rick Doblin Interview on Psychedelic Research and Culture